SHAY BARFIELD: Open Payments
NPI 1942785100 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 43 payments from 12 companies in 2025. Trend: 2023 $45 · 2024 $685 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $315 |
| Novo Nordisk Inc | 7 | $228 |
| AstraZeneca Pharmaceuticals LP | 9 | $202 |
| PFIZER INC. | 3 | $49 |
| Dexcom, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| ViiV Healthcare Company | 2 | $35 |
| Lilly USA, LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $32 |
| Tandem Diabetes Care, Inc. | 1 | $22 |
Products named: Ozempic, VRAYLAR, BREZTRI, UBRELVY, QULIPTA, FARXIGA, AIRSUPRA, PREVNAR 20.
Industry payments across AR — which companies pay providers there.
